| No. |
Name Length
|
Chromosome No./Scaffold Id Scaffold Length |
BLAST (vs nr) |
Gene ontology |
| 11641 |
O_BomaASG20478_3prime_partial:A_BomaASG_c33093_g1_i2
237bp |
|
PREDICTED:_general_transcription_factor_3C_polypeptide_3_[Papilio_machaon] |
| GO:0000127 |
C |
transcription factor TFIIIC complex |
| GO:0003677 |
F |
DNA binding |
| GO:0005515 |
F |
protein binding |
| GO:0005634 |
C |
nucleus |
| GO:0005654 |
C |
nucleoplasm |
| GO:0005730 |
C |
nucleolus |
| GO:0006351 |
P |
transcription, DNA-templated |
| GO:0006383 |
P |
transcription by RNA polymerase III |
| GO:0031965 |
C |
nuclear membrane |
| GO:0042791 |
P |
5S class rRNA transcription by RNA polymerase III |
| GO:0042797 |
P |
tRNA transcription by RNA polymerase III |
|
| 11642 |
O_BomaASG20479_5prime_partial:A_BomaASG_c33094_g1_i1
449bp |
|
cell_wall_protein_RBR3-like_[Bombyx_mori] |
|
| 11643 |
O_BomaASG2047_complete:A_BomaASG_c13616_g1_i1
166bp |
|
|
|
| 11644 |
O_BomaASG20480_complete:A_BomaASG_c33094_g1_i1
101bp |
|
|
|
| 11645 |
O_BomaASG20481_5prime_partial:A_BomaASG_c33094_g1_i2
517bp |
|
cell_wall_protein_RBR3-like_[Bombyx_mori] |
|
| 11646 |
O_BomaASG20482_complete:A_BomaASG_c33094_g1_i2
101bp |
|
|
|
| 11647 |
O_BomaASG20483_complete:A_BomaASG_c33094_g1_i3
513bp |
|
cell_wall_protein_RBR3-like_[Bombyx_mori] |
|
| 11648 |
O_BomaASG20484_complete:A_BomaASG_c33094_g1_i3
101bp |
|
|
|
| 11649 |
O_BomaASG20485_complete:A_BomaASG_c33095_g1_i1
280bp |
|
guanylate_cyclase_32E_[Bombyx_mori] |
| GO:0000166 |
F |
nucleotide binding |
| GO:0004383 |
F |
guanylate cyclase activity |
| GO:0004672 |
F |
protein kinase activity |
| GO:0005524 |
F |
ATP binding |
| GO:0005525 |
F |
GTP binding |
| GO:0005622 |
C |
intracellular anatomical structure |
| GO:0006182 |
P |
cGMP biosynthetic process |
| GO:0006468 |
P |
protein phosphorylation |
| GO:0009190 |
P |
cyclic nucleotide biosynthetic process |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016829 |
F |
lyase activity |
| GO:0016849 |
F |
phosphorus-oxygen lyase activity |
| GO:0035556 |
P |
intracellular signal transduction |
|
| 11650 |
O_BomaASG20486_3prime_partial:A_BomaASG_c33095_g1_i2
254bp |
|
guanylate_cyclase_32E_[Bombyx_mori] |
| GO:0000166 |
F |
nucleotide binding |
| GO:0004016 |
F |
adenylate cyclase activity |
| GO:0004383 |
F |
guanylate cyclase activity |
| GO:0004672 |
F |
protein kinase activity |
| GO:0005524 |
F |
ATP binding |
| GO:0005525 |
F |
GTP binding |
| GO:0005886 |
C |
plasma membrane |
| GO:0005887 |
C |
integral component of plasma membrane |
| GO:0006182 |
P |
cGMP biosynthetic process |
| GO:0006468 |
P |
protein phosphorylation |
| GO:0007166 |
P |
cell surface receptor signaling pathway |
| GO:0007168 |
P |
receptor guanylyl cyclase signaling pathway |
| GO:0007186 |
P |
G protein-coupled receptor signaling pathway |
| GO:0007589 |
P |
body fluid secretion |
| GO:0008074 |
C |
guanylate cyclase complex, soluble |
| GO:0008217 |
P |
regulation of blood pressure |
| GO:0008528 |
F |
G protein-coupled peptide receptor activity |
| GO:0009190 |
P |
cyclic nucleotide biosynthetic process |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016525 |
P |
negative regulation of angiogenesis |
| GO:0016829 |
F |
lyase activity |
| GO:0016849 |
F |
phosphorus-oxygen lyase activity |
| GO:0016941 |
F |
natriuretic peptide receptor activity |
| GO:0017046 |
F |
peptide hormone binding |
| GO:0019901 |
F |
protein kinase binding |
| GO:0030308 |
P |
negative regulation of cell growth |
| GO:0030828 |
P |
obsolete positive regulation of cGMP biosynthetic process |
| GO:0035556 |
P |
intracellular signal transduction |
| GO:0035810 |
P |
positive regulation of urine volume |
| GO:0035815 |
P |
positive regulation of renal sodium excretion |
| GO:0042312 |
P |
blood vessel diameter maintenance |
| GO:0042417 |
P |
dopamine metabolic process |
| GO:0042562 |
F |
hormone binding |
| GO:0043114 |
P |
regulation of vascular permeability |
| GO:0043235 |
C |
receptor complex |
| GO:0048662 |
P |
negative regulation of smooth muscle cell proliferation |
| GO:0050880 |
P |
blood vessel diameter maintenance |
| GO:1903779 |
P |
regulation of cardiac conduction |
|
| 11651 |
O_BomaASG20487_complete:A_BomaASG_c33095_g1_i3
560bp |
|
guanylate_cyclase_32E_[Bombyx_mori] |
| GO:0000166 |
F |
nucleotide binding |
| GO:0004016 |
F |
adenylate cyclase activity |
| GO:0004383 |
F |
guanylate cyclase activity |
| GO:0004672 |
F |
protein kinase activity |
| GO:0004872 |
F |
signaling receptor activity |
| GO:0005524 |
F |
ATP binding |
| GO:0005525 |
F |
GTP binding |
| GO:0005886 |
C |
plasma membrane |
| GO:0005887 |
C |
integral component of plasma membrane |
| GO:0006182 |
P |
cGMP biosynthetic process |
| GO:0006468 |
P |
protein phosphorylation |
| GO:0007165 |
P |
signal transduction |
| GO:0008074 |
C |
guanylate cyclase complex, soluble |
| GO:0009190 |
P |
cyclic nucleotide biosynthetic process |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016829 |
F |
lyase activity |
| GO:0016849 |
F |
phosphorus-oxygen lyase activity |
| GO:0019934 |
P |
cGMP-mediated signaling |
| GO:0035556 |
P |
intracellular signal transduction |
|
| 11652 |
O_BomaASG20488_3prime_partial:A_BomaASG_c33095_g1_i3
488bp |
|
guanylate_cyclase_32E_[Bombyx_mori] |
| GO:0000166 |
F |
nucleotide binding |
| GO:0004016 |
F |
adenylate cyclase activity |
| GO:0004383 |
F |
guanylate cyclase activity |
| GO:0004672 |
F |
protein kinase activity |
| GO:0005515 |
F |
protein binding |
| GO:0005524 |
F |
ATP binding |
| GO:0005525 |
F |
GTP binding |
| GO:0005886 |
C |
plasma membrane |
| GO:0006182 |
P |
cGMP biosynthetic process |
| GO:0006468 |
P |
protein phosphorylation |
| GO:0007166 |
P |
cell surface receptor signaling pathway |
| GO:0007168 |
P |
receptor guanylyl cyclase signaling pathway |
| GO:0008074 |
C |
guanylate cyclase complex, soluble |
| GO:0009190 |
P |
cyclic nucleotide biosynthetic process |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016829 |
F |
lyase activity |
| GO:0016849 |
F |
phosphorus-oxygen lyase activity |
| GO:0016941 |
F |
natriuretic peptide receptor activity |
| GO:0017046 |
F |
peptide hormone binding |
| GO:0019901 |
F |
protein kinase binding |
| GO:0030828 |
P |
obsolete positive regulation of cGMP biosynthetic process |
| GO:0035556 |
P |
intracellular signal transduction |
| GO:0042417 |
P |
dopamine metabolic process |
| GO:0042562 |
F |
hormone binding |
| GO:0043235 |
C |
receptor complex |
| GO:0048662 |
P |
negative regulation of smooth muscle cell proliferation |
| GO:0050880 |
P |
blood vessel diameter maintenance |
|
| 11653 |
O_BomaASG20489_internal:A_BomaASG_c33095_g1_i5
582bp |
|
guanylate_cyclase_32E_[Bombyx_mori] |
| GO:0000166 |
F |
nucleotide binding |
| GO:0004016 |
F |
adenylate cyclase activity |
| GO:0004383 |
F |
guanylate cyclase activity |
| GO:0004672 |
F |
protein kinase activity |
| GO:0005515 |
F |
protein binding |
| GO:0005524 |
F |
ATP binding |
| GO:0005525 |
F |
GTP binding |
| GO:0005886 |
C |
plasma membrane |
| GO:0006182 |
P |
cGMP biosynthetic process |
| GO:0006468 |
P |
protein phosphorylation |
| GO:0007166 |
P |
cell surface receptor signaling pathway |
| GO:0007168 |
P |
receptor guanylyl cyclase signaling pathway |
| GO:0008074 |
C |
guanylate cyclase complex, soluble |
| GO:0009190 |
P |
cyclic nucleotide biosynthetic process |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016829 |
F |
lyase activity |
| GO:0016849 |
F |
phosphorus-oxygen lyase activity |
| GO:0016941 |
F |
natriuretic peptide receptor activity |
| GO:0017046 |
F |
peptide hormone binding |
| GO:0019901 |
F |
protein kinase binding |
| GO:0030828 |
P |
obsolete positive regulation of cGMP biosynthetic process |
| GO:0035556 |
P |
intracellular signal transduction |
| GO:0042417 |
P |
dopamine metabolic process |
| GO:0042562 |
F |
hormone binding |
| GO:0043235 |
C |
receptor complex |
| GO:0048662 |
P |
negative regulation of smooth muscle cell proliferation |
| GO:0050880 |
P |
blood vessel diameter maintenance |
|
| 11654 |
O_BomaASG2048_complete:A_BomaASG_c13616_g1_i1
163bp |
|
|
|
| 11655 |
O_BomaASG20490_internal:A_BomaASG_c33095_g1_i6
194bp |
|
guanylate_cyclase_32E_[Bombyx_mori] |
| GO:0000166 |
F |
nucleotide binding |
| GO:0004016 |
F |
adenylate cyclase activity |
| GO:0004383 |
F |
guanylate cyclase activity |
| GO:0004672 |
F |
protein kinase activity |
| GO:0005524 |
F |
ATP binding |
| GO:0005525 |
F |
GTP binding |
| GO:0005886 |
C |
plasma membrane |
| GO:0005887 |
C |
integral component of plasma membrane |
| GO:0006182 |
P |
cGMP biosynthetic process |
| GO:0006468 |
P |
protein phosphorylation |
| GO:0007166 |
P |
cell surface receptor signaling pathway |
| GO:0007168 |
P |
receptor guanylyl cyclase signaling pathway |
| GO:0007186 |
P |
G protein-coupled receptor signaling pathway |
| GO:0007589 |
P |
body fluid secretion |
| GO:0008074 |
C |
guanylate cyclase complex, soluble |
| GO:0008217 |
P |
regulation of blood pressure |
| GO:0008528 |
F |
G protein-coupled peptide receptor activity |
| GO:0009190 |
P |
cyclic nucleotide biosynthetic process |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016525 |
P |
negative regulation of angiogenesis |
| GO:0016829 |
F |
lyase activity |
| GO:0016849 |
F |
phosphorus-oxygen lyase activity |
| GO:0016941 |
F |
natriuretic peptide receptor activity |
| GO:0017046 |
F |
peptide hormone binding |
| GO:0019901 |
F |
protein kinase binding |
| GO:0030308 |
P |
negative regulation of cell growth |
| GO:0030828 |
P |
obsolete positive regulation of cGMP biosynthetic process |
| GO:0035556 |
P |
intracellular signal transduction |
| GO:0035810 |
P |
positive regulation of urine volume |
| GO:0035815 |
P |
positive regulation of renal sodium excretion |
| GO:0042312 |
P |
blood vessel diameter maintenance |
| GO:0042417 |
P |
dopamine metabolic process |
| GO:0042562 |
F |
hormone binding |
| GO:0043114 |
P |
regulation of vascular permeability |
| GO:0043235 |
C |
receptor complex |
| GO:0048662 |
P |
negative regulation of smooth muscle cell proliferation |
| GO:0050880 |
P |
blood vessel diameter maintenance |
| GO:1903779 |
P |
regulation of cardiac conduction |
|
| 11656 |
O_BomaASG20491_complete:A_BomaASG_c33095_g1_i7
465bp |
|
guanylate_cyclase_32E_[Bombyx_mori] |
| GO:0000166 |
F |
nucleotide binding |
| GO:0004016 |
F |
adenylate cyclase activity |
| GO:0004383 |
F |
guanylate cyclase activity |
| GO:0004672 |
F |
protein kinase activity |
| GO:0004872 |
F |
signaling receptor activity |
| GO:0005524 |
F |
ATP binding |
| GO:0005525 |
F |
GTP binding |
| GO:0005886 |
C |
plasma membrane |
| GO:0005887 |
C |
integral component of plasma membrane |
| GO:0006182 |
P |
cGMP biosynthetic process |
| GO:0006468 |
P |
protein phosphorylation |
| GO:0007165 |
P |
signal transduction |
| GO:0008074 |
C |
guanylate cyclase complex, soluble |
| GO:0009190 |
P |
cyclic nucleotide biosynthetic process |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016829 |
F |
lyase activity |
| GO:0016849 |
F |
phosphorus-oxygen lyase activity |
| GO:0019934 |
P |
cGMP-mediated signaling |
| GO:0035556 |
P |
intracellular signal transduction |
|
| 11657 |
O_BomaASG20492_3prime_partial:A_BomaASG_c33095_g1_i8
432bp |
|
guanylate_cyclase_32E_[Bombyx_mori] |
| GO:0000166 |
F |
nucleotide binding |
| GO:0004016 |
F |
adenylate cyclase activity |
| GO:0004383 |
F |
guanylate cyclase activity |
| GO:0004672 |
F |
protein kinase activity |
| GO:0005515 |
F |
protein binding |
| GO:0005524 |
F |
ATP binding |
| GO:0005525 |
F |
GTP binding |
| GO:0005886 |
C |
plasma membrane |
| GO:0006182 |
P |
cGMP biosynthetic process |
| GO:0006468 |
P |
protein phosphorylation |
| GO:0007166 |
P |
cell surface receptor signaling pathway |
| GO:0007168 |
P |
receptor guanylyl cyclase signaling pathway |
| GO:0008074 |
C |
guanylate cyclase complex, soluble |
| GO:0009190 |
P |
cyclic nucleotide biosynthetic process |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016829 |
F |
lyase activity |
| GO:0016849 |
F |
phosphorus-oxygen lyase activity |
| GO:0016941 |
F |
natriuretic peptide receptor activity |
| GO:0017046 |
F |
peptide hormone binding |
| GO:0019901 |
F |
protein kinase binding |
| GO:0030828 |
P |
obsolete positive regulation of cGMP biosynthetic process |
| GO:0035556 |
P |
intracellular signal transduction |
| GO:0042417 |
P |
dopamine metabolic process |
| GO:0042562 |
F |
hormone binding |
| GO:0043235 |
C |
receptor complex |
| GO:0048662 |
P |
negative regulation of smooth muscle cell proliferation |
| GO:0050880 |
P |
blood vessel diameter maintenance |
|
| 11658 |
O_BomaASG20493_3prime_partial:A_BomaASG_c33096_g1_i1
188bp |
|
homeotic_protein_female_sterile_isoform_X4_[Bombyx_mori] |
| GO:0003677 |
F |
DNA binding |
| GO:0004672 |
F |
protein kinase activity |
| GO:0005634 |
C |
nucleus |
| GO:0006357 |
P |
regulation of transcription by RNA polymerase II |
| GO:0006468 |
P |
protein phosphorylation |
| GO:0007275 |
P |
multicellular organism development |
| GO:0007362 |
P |
terminal region determination |
| GO:0007476 |
P |
imaginal disc-derived wing morphogenesis |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0032968 |
P |
positive regulation of transcription elongation from RNA polymerase II promoter |
| GO:0045892 |
P |
negative regulation of transcription, DNA-templated |
|
| 11659 |
O_BomaASG20494_3prime_partial:A_BomaASG_c33096_g1_i3
188bp |
|
homeotic_protein_female_sterile_isoform_X4_[Bombyx_mori] |
| GO:0003677 |
F |
DNA binding |
| GO:0004672 |
F |
protein kinase activity |
| GO:0005634 |
C |
nucleus |
| GO:0006357 |
P |
regulation of transcription by RNA polymerase II |
| GO:0006468 |
P |
protein phosphorylation |
| GO:0007275 |
P |
multicellular organism development |
| GO:0007362 |
P |
terminal region determination |
| GO:0007476 |
P |
imaginal disc-derived wing morphogenesis |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0032968 |
P |
positive regulation of transcription elongation from RNA polymerase II promoter |
| GO:0045892 |
P |
negative regulation of transcription, DNA-templated |
|
| 11660 |
O_BomaASG20495_internal:A_BomaASG_c33097_g1_i1
138bp |
|
GRAM_domain-containing_protein_1B_isoform_X2_[Bombyx_mori] |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
|
| 11661 |
O_BomaASG20496_3prime_partial:A_BomaASG_c33097_g1_i2
487bp |
|
GRAM_domain-containing_protein_1B_isoform_X1_[Bombyx_mori] |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
|
| 11662 |
O_BomaASG20497_complete:A_BomaASG_c33097_g1_i2
172bp |
|
|
|
| 11663 |
O_BomaASG20498_complete:A_BomaASG_c33097_g1_i2
129bp |
|
|
|
| 11664 |
O_BomaASG20499_5prime_partial:A_BomaASG_c33097_g2_i1
217bp |
|
GRAM_domain-containing_protein_1B_isoform_X1_[Bombyx_mori] |
| GO:0005515 |
F |
protein binding |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
|
| 11665 |
O_BomaASG2049_complete:A_BomaASG_c13616_g1_i1
141bp |
|
Uncharacterized_protein_C2orf47-like,_mitochondrial_[Papilio_machaon] |
|
| 11666 |
O_BomaASG204_5prime_partial:A_BomaASG_c1122_g1_i1
121bp |
|
|
|
| 11667 |
O_BomaASG20500_3prime_partial:A_BomaASG_c33097_g2_i1
150bp |
|
|
|
| 11668 |
O_BomaASG20501_complete:A_BomaASG_c33097_g2_i1
100bp |
|
|
|
| 11669 |
O_BomaASG20502_internal:A_BomaASG_c33098_g1_i1
343bp |
|
|
|
| 11670 |
O_BomaASG20503_internal:A_BomaASG_c33098_g1_i1
343bp |
|
PREDICTED:_LOW_QUALITY_PROTEIN:_endoribonuclease_Dcr-1_[Papilio_xuthus] |
| GO:0000166 |
F |
nucleotide binding |
| GO:0003723 |
F |
RNA binding |
| GO:0003725 |
F |
double-stranded RNA binding |
| GO:0003727 |
F |
single-stranded RNA binding |
| GO:0004386 |
F |
helicase activity |
| GO:0004518 |
F |
nuclease activity |
| GO:0004519 |
F |
endonuclease activity |
| GO:0004525 |
F |
ribonuclease III activity |
| GO:0004530 |
F |
deoxyribonuclease I activity |
| GO:0005515 |
F |
protein binding |
| GO:0005524 |
F |
ATP binding |
| GO:0005634 |
C |
nucleus |
| GO:0005737 |
C |
cytoplasm |
| GO:0006309 |
P |
apoptotic DNA fragmentation |
| GO:0006396 |
P |
RNA processing |
| GO:0007279 |
P |
pole cell formation |
| GO:0007294 |
P |
germarium-derived oocyte fate determination |
| GO:0007367 |
P |
segment polarity determination |
| GO:0016246 |
P |
RNA interference |
| GO:0016442 |
C |
RISC complex |
| GO:0016443 |
F |
bidentate ribonuclease III activity |
| GO:0016787 |
F |
hydrolase activity |
| GO:0016891 |
F |
endoribonuclease activity, producing 5'-phosphomonoesters |
| GO:0030422 |
P |
production of siRNA involved in RNA interference |
| GO:0030727 |
P |
germarium-derived female germ-line cyst formation |
| GO:0031047 |
P |
gene silencing by RNA |
| GO:0031054 |
P |
pre-miRNA processing |
| GO:0033227 |
P |
dsRNA transport |
| GO:0035087 |
P |
siRNA loading onto RISC involved in RNA interference |
| GO:0035196 |
P |
production of miRNAs involved in gene silencing by miRNA |
| GO:0042078 |
P |
germ-line stem cell division |
| GO:0042594 |
P |
response to starvation |
| GO:0045448 |
P |
mitotic cell cycle, embryonic |
| GO:0046872 |
F |
metal ion binding |
| GO:0048813 |
P |
dendrite morphogenesis |
| GO:0070883 |
F |
pre-miRNA binding |
| GO:0090501 |
P |
RNA phosphodiester bond hydrolysis |
| GO:0090502 |
P |
RNA phosphodiester bond hydrolysis, endonucleolytic |
|